Data supports Sight Sciences' Omni surgical system for glaucoma
Sight Sciences announced today that 36-month data supports the use of its Omni surgical system.
Source: massdevice.com
Stay updated with breaking news from Karsten Klabe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sight Sciences announced today that 36-month data supports the use of its Omni surgical system.
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced